Immunotherapy of Acute Myeloid Leukemia: Current Approaches

被引:45
|
作者
Smits, Evelien L. J. M. [1 ]
Berneman, Zwi N. [1 ,2 ]
Van Tendeloo, Viggo F. I. [1 ,2 ]
机构
[1] Univ Antwerp, Fac Med, VIDI, Lab Expt Hematol, B-2650 Antwerp, Belgium
[2] Univ Antwerp Hosp, Ctr Cellular Therapy & Regenerat Med, Antwerp, Belgium
来源
ONCOLOGIST | 2009年 / 14卷 / 03期
关键词
Myeloid leukemia; Active immunotherapy; Passive immunotherapy; CYTOTOXIC T-LYMPHOCYTES; ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; COLONY-STIMULATING FACTOR; ADVANCED MYELODYSPLASTIC SYNDROME; AUTOLOGOUS DENDRITIC CELLS; MEDIATED GENE-TRANSFER; SHORT-TERM CULTURE; IN-VITRO; WT1; PEPTIDE;
D O I
10.1634/theoncologist.2008-0165
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Following standard therapy that consists of chemotherapy with or without stem cell transplantation, both relapsed and refractory disease shorten the survival of acute myeloid leukemia (AML) patients. Therefore, additional treatment options are urgently needed, especially to fight residual AML cells. The identification of leukemia-associated antigens and the observation that administration of allogeneic T cells can mediate a graft-versus-leukemia effect paved the way to the development of active and passive immunotherapy strategies, respectively. The aim of these strategies is the eradication of AML cells by the immune system. In this review, an overview is provided of both active and passive immunotherapy strategies that are under investigation or in use for the treatment of AML. For each strategy, a critical view on the state of the art is given and future perspectives are discussed. The Oncologist 2009; 14: 240-252
引用
收藏
页码:240 / 252
页数:13
相关论文
共 50 条
  • [1] New Approaches for the Immunotherapy of Acute Myeloid Leukemia
    Geiger, Terrence L.
    Rubnitz, Jeffrey E.
    [J]. DISCOVERY MEDICINE, 2015, 19 (105) : 275 - 284
  • [2] Novel Approaches to Acute Myeloid Leukemia Immunotherapy
    Beyar-Katz, Ofrat
    Gill, Saar
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (22) : 5502 - 5515
  • [3] Current status of immunotherapy in acute myeloid leukemia
    Subklewe, Marion
    [J]. HEMASPHERE, 2018, 2 : 15 - 18
  • [4] Current strategies in immunotherapy for acute myeloid leukemia
    Lichtenegger, Felix S.
    Schnorfeil, Frauke M.
    Hiddemann, Wolfgang
    Subklewe, Marion
    [J]. IMMUNOTHERAPY, 2013, 5 (01) : 63 - 78
  • [5] The progress and current status of immunotherapy in acute myeloid leukemia
    Yang, Dan
    Zhang, Xiuqun
    Zhang, Xuezhong
    Xu, Yanli
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (12) : 1965 - 1982
  • [6] The progress and current status of immunotherapy in acute myeloid leukemia
    Dan Yang
    Xiuqun Zhang
    Xuezhong Zhang
    Yanli Xu
    [J]. Annals of Hematology, 2017, 96 : 1965 - 1982
  • [7] Immunotherapy for acute myeloid leukemia: current trends, challenges, and strategies
    Chen, Evan C.
    Garcia, Jacqueline S.
    [J]. ACTA HAEMATOLOGICA, 2024, 147 (02) : 200 - 220
  • [8] A perspective of immunotherapy for acute myeloid leukemia : Current advances and challenges
    Chen, Ying
    Wang, Jishi
    Zhang, Fengqi
    Liu, Ping
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] IMMUNOTHERAPY FOR ACUTE MYELOID LEUKEMIA
    HOCKER, P
    PITTERMANN, E
    LUTZ, D
    [J]. BLUT, 1976, 33 (03): : 195 - 195
  • [10] Immunotherapy for acute myeloid leukemia
    Jurcic J.G.
    [J]. Current Oncology Reports, 2005, 7 (5) : 339 - 346